Male Pattern Baldness Research

While scientists have yet to produce a baldness cure, research continues to yield new forms of baldness treatment and other hopeful results for men with male pattern baldness. Though not all research yields good news for balding men, staying on top of the research is a good idea if you’re worried about your baldness or looking for an appropriate baldness treatment. Below are the three most noteworthy areas of modern baldness research and baldness treatment methods.

New Cause of Male Pattern Baldness Discovered

Researchers at the University of Pennsylvania have discovered that male pattern baldness has less to do with follicles failing to make hair as with follicles making hair that’s too thin to see (Garza, et al., 2011). The good news is that the stem cells that make hair are still present, so stimulating them to make thicker, longer hair could reverse male pattern baldness. While researchers are far from finding a baldness cure, research in this area provides some of the most exciting possibilities for new baldness treatment techniques.

Pharmaceutical Company Developing New Baldness Drug

A drug commonly used to treat benign enlarged prostates in men has also been found to be an effective new baldness treatment. dutasteride, commonly called Avodart®, works to prohibit the production of dihydrotestosterone (DHT), a major cause of male pattern baldness, more effectively than common baldness medication finasteride (Propecia®). In an extensive clinical study, a lower dose of dutasteride was more effective as a new baldness treatment, re-growing hair in more men than finasteride (Oslen, et al., 2010). This, however, is not a baldness cure; research must continue on dutasteride before it is considered safe and effective for the treatment of baldness.

Baldness Linked to Greater Cancer Risk

A French baldness research study found that men with prostate cancer were almost twice as likely to begin showing signs of male pattern baldness in their 20s. This was not true of men who developed baldness in their 30s or 40s. The good news is that new baldness treatment drugs like finasteride and dutasteride may also work to lower the risk of prostate cancer. Talk to your doctor if you’re worried about your risk.

Resources

Garza, L., et al. (2011). Bald scalp in men with androgenetic alopecia retains hair follicle stem cells but lacks CD200-rich and CD34-positive hair follicle progenitor cells. Retrieved March 10, 2011, from http://www.jci.org/articles/view/44478?key=0a1481860c0b098075c7

Mozales, A. (2011). Balding linked to cancer risk. Retrieved March 9, 2011, from http://www.suntimes.com/lifestyles/4186056-423/balding-linked-to-cancer-risk.html

Olsen, E., et al. (2006). The importance of dual 5a-reductase inhibition in the treatment of male pattern hair loss. Retrieved March 9, 2011, from http://www.bernsteinmedical.com/resources/hair-restoration-papers/dutasteride-vs-finasteride/

Roberts, M. (2011). Cause of male baldness discovered, experts say. Retrieved March 9, 2011 from http://www.bbc.co.uk/news/health-12112673